Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
23 Agosto 2024 - 6:00PM
UK Regulatory
Report of transactions of shares and related securities of Bavarian
Nordic by persons holding managerial responsibilities and/or
persons/companies closely associated with such
COPENHAGEN, Denmark, August 23,
2024 – Bavarian Nordic A/S (OMX: BAVA) has today received
information about the following transactions of the company’s
shares/related securities by persons holding managerial
responsibilities and/or persons/companies closely associated with
such.
1. |
Details of the person discharging managerial
responsibilities/person closely associated |
a) |
Name |
Karen Merete Jensen |
2. |
Reason for the notification |
a) |
Position/status |
Member of the Board of Bavarian Nordic A/S (employee-elected) |
b) |
Initial notification/Amendment |
Initial notification |
3. |
Details of the issuer, emission allowance market
participant, auction platform, auctioneer or auction
monitor |
a) |
Name |
Bavarian Nordic A/S |
b) |
LEI |
2138006JCDVYIN6INP51 |
4. |
Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted |
a) |
Description of the financial instrument, type of instrument
Identification code |
Shares
DK0015998017 |
b) |
Nature of the transaction |
Sale |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
|
DKK 275.97 |
200 |
d) |
Aggregated information
|
200
DKK 55,193.00 |
e) |
Date of the transaction |
2024-08-22 |
f) |
Place of the transaction |
Nasdaq Copenhagen A/S, XCSE |
About Bavarian Nordic
Bavarian Nordic is a fully integrated vaccine company with a
mission to protect and save lives through innovative vaccines. We
are a global leader in smallpox and mpox vaccines, supplied to
governments to enhance public health preparedness and have a strong
portfolio of vaccines for travelers and endemic diseases. For more
information visit www.bavarian-nordic.com.
Contacts
Europe: Rolf Sass Sørensen, Vice President Investor Relations,
rss@bavarian-nordic.com, Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors,
graham@paddockcircle.com, Tel: +1 781 686 9600
Company Announcement no. 26 / 2024
Grafico Azioni Bavarian Nordic AS (TG:BV3)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Bavarian Nordic AS (TG:BV3)
Storico
Da Nov 2023 a Nov 2024